Happy Camper: How Stella Armstrong Cured Her Hep C

Analysis of nearly 34,000 people finds no serious adverse events associated with direct-acting antiviral therapy.

Researchers analyzed PPIs’ potential effects on nearly 2,400 participants of nine studies of Mavyret.

Advocates at the Global Liver Institute are declaring the liver disease a “hidden epidemic” across the globe.

Chronic inflammation is associated with numerous harms.

Medicare plans vary and can sometimes be difficult to decipher. Does your plan cover hepatitis C treatment?

A study conducted in Australia treated people attending a syringe services program.

A new study finds strong support for the harm reduction strategy among those most likely to use them.

Keytruda showed modest benefits for people with hepatocellular carcinoma, and combining Opdivo with Yervoy improved outcomes.